Yumanity Therapeutics, Inc. Common Stock

Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday. Surrozen, Inc. (NASDAQ: SRZN) shares rose 67.3% to $0.7291 in pre-market trading. The company, last month, posted a narrower Q3 loss. Crown ElectroKinetics Corp. (NASDAQ: CRKN) rose 54.1% to $0.2366 in pre-market trading after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. Core Scientific, Inc. (NASDAQ: CORZ) rose 53% to $0.3826 in pre-market trading after B. Riley Financial issued an open letter to Core Scientific shareholders and lenders. Jounce Therapeutics, Inc. (NASDAQ: JNCE) shares rose 23.4% to $0.8499 in pre-market trading. Jounce Therapeutics recently presented INNATE Phase 1 and SELECT clinical trial data at the European Society of Medical Oncology Immuno-Oncology Annual Congress. Gritstone bio, Inc. (NASDAQ: GRTS) rose 14.8% to $4.50 in pre-market trading after jumping 26% on Wednesday. Gritstone bio was recently granted two new US patents for self-amplifying mRNA. E-Home Household Service Holdings Limited (NASDAQ: EJH) rose 12.2% to $0.5796 in pre-market trading after gaining 6% on Wednesday. Sio Gene Therapies Inc (NASDAQ: SIOX) rose 11.6% to $0.40 in pre-market trading. On December 14, 2022, the company’s board unanimously approved the dissolution and liquidation of the company pursuant to a plan of complete liquidation and dissolution. Quotient Limited (NASDAQ: QTNT) ...

Related tickers: ABCL, WNW, ATHX, SCPS, NVAX, YMTX, PL, VLON, TSLA, EJH, GLYC, AMAM, QTNT, ICVX, BIMI, SRZN, DS, BRDS, COSM, AIRS, JNCE, CORZ, GRTS, NOGN, ALIT, GETR, CRKN, SIOX.

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 140% to $0.6041 after the company entered into a definitive merger agreement with GRI Bio. Immix Biopharma, Inc. (NASDAQ: IMMX) jumped 46% to $2.1695 after the company announced it has in-licensed BCMA-targeted next-generation CAR-T therapy NXC-201 with 85% ORR and 71% CR/sCR at the therapeutic dose from the first 20 patients in an ongoing phase 1b relapsed/refractory multiple myeloma ongoing clinical trial. Senti Biosciences, Inc. (NASDAQ: SNTI) rose 45% to $2.09 after dipping more than 21% on Tuesday. Avidity Biosciences, Inc. (NASDAQ: RNA) shares climbed 44.3% to $15.84 after the company announced AOC 1001 data from the preliminary assessment of the Phase 1/2 MARINA trial demonstrating the first-ever successful targeted delivery of RNA into muscle. BIMI International Medical, Inc. (NASDAQ: BIMI) gained 28.1% to $2.6649. BIMI reported entry into a material definitive agreement for the acquisition of Wuzhou Qiangsheng Hospital Co., Ltd., Suzhou Eurasia Hospital Co., Ltd. and Yunan Yuxi Minkang Hospital Co., Ltd. Wave Life Sciences Ltd. (NASDAQ: WVE) gained 21.1% to $5.80. SVB Leerink maintained WAVE Life Sciences with a Market Perform and raised the price target from $2 to $7. Kymera Therapeutics, Inc. (NASDAQ: KYMR) shares gained 21.4% to $31.38 after the company announced results from the Phase 1 clinical trial evaluating KT-474 in patients with HS and AD and Sanofi's decision to advance KT-474 into Phase 2 clinical trials. Aspen Group, Inc. (NASDAQ: ASPU) gained 17.4% to $0.41 after reporting strong quarterly sales. REV Group, Inc. (NYSE: REVG) jumped 17.2% to $15.57 as the company reported a fourth-quarter FY22 sales growth ...

Related tickers: OPGN, KYMR, DFLI, WVE, KSPN, GETR, ZVSA, SFR, SIOX, CYTK, REVG, NVVE, HLIT, AVDL, NCPL, RBCN, NXL, PBLA, CHTR, CVNA, WNW, QTEK, PCSA, YMTX, SMMT, ASPU, VS, VINC, DYN, PHCF, VLON, RNA, HROW, LVTX, UIHC, SQL, BHG, SNTI, HAPP, BTB, BIMI, OCG, ARQQ, OTIC, BXRX, MULN, DS, CRKN, IMMX.